KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Capital Expenditures (2016 - 2025)

Precigen (PGEN) has disclosed Capital Expenditures for 14 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 75.56% to -$1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $214000.0 through Dec 2025, down 37.24% year-over-year, with the annual reading at $214000.0 for FY2025, 37.24% down from the prior year.
  • Capital Expenditures for Q4 2025 was -$1.8 million at Precigen, down from $389000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $4.7 million in Q4 2022, with the low at -$7.2 million in Q4 2024.
  • Average Capital Expenditures over 5 years is $664600.0, with a median of $809500.0 recorded in 2023.
  • Peak annual rise in Capital Expenditures hit 2725.32% in 2024, while the deepest fall reached 3402.43% in 2024.
  • Over 5 years, Capital Expenditures stood at $2.8 million in 2021, then surged by 70.39% to $4.7 million in 2022, then crashed by 104.36% to -$206000.0 in 2023, then crashed by 3402.43% to -$7.2 million in 2024, then soared by 75.56% to -$1.8 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at -$1.8 million, $389000.0, and $722000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.